Skip to content

Effects of dexmedetomidine Infusion on acute postoperative ICU pain management and opioid consumption in elective cardiac surgery via median sternotomy: A randomized controlled trial

Effects of dexmedetomidine Infusion on acute postoperative ICU pain management and opioid consumption in elective cardiac surgery via median sternotomy: A randomized controlled trial

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20250830003
Enrollment
62
Registered
2025-08-30
Start date
2025-04-30
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The primary health problem studied in this research is acute postoperative pain following elective cardiac surgery via median sternotomy. The study investigates the potential of dexmedetomidine infusion to improve pain management and reduce opioid consumption in this patient population Okay, here are the keywords from the research proposal, one per line: Dexmedetomidine Postoperative Pain Cardiac Surgery Median Sternotomy Opioid Consumption Pain Management

Interventions

Dexmedetomidine infusion will be initiated at a rate of 0.5 micrograms per kilogram of actual body weight per hour for 12 hours in the intervention group.,In the placebo group, patients will receive a
Experimental Drug,Placebo Comparator No treatment

Sponsors

Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
20 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients who admitted at Maharaj Nakorn Chiang Mai Hospital with aged between 20 and 80 years old 2. Scheduled for elective cardiac surgery via median sternotomy (with or without cardiopulmonary bypass), including CABG or OPCAB, and combined CABG and valve surgery.

Exclusion criteria

Exclusion criteria: 1. Patients who known as hypersensitivity or allergy to dexmedetomidine 2. Patients with chronic opioid use or opioid dependent 3. Underlying renal impairment (Crcl < 30) 4. Underlying Hepatic impairment (AST or ALT > 2 times) 5. Pacemaker or intracardiac devices before surgery 6. Bradycardia or arrhythmia 7. Patients with LVEF equal or lower than 40% 8. Pregnancy or Breastfeeding 9. Psychiatric patient 10.BMI > 30 kg/m2 11.Parasternal block 12.Previous cardiac surgery via median sternotomy

Design outcomes

Primary

MeasureTime frame
pain score postoperatively after arrival at ICU 0,2,4,6,8,10 and 12 hours postoperatively standard 10-cm visual analog scale (VAS),Opioid consumption until discharge from ICU Measured as the total cumulative dose of intravenous fentanyl (in micrograms) used from ICU admission until ICU discharge.

Secondary

MeasureTime frame
Time to extubation after ICU admission Recorded in hours from ICU admission to successful removal of the endotracheal tube,Sedation score assessed at 0,2,4,6, 8,10 and 12 hours postoperatively Assessed using the Richmond Agitation-Sedation Scale (RASS),Length of ICU and hospital stay until patient discharge Measured in days, obtained from electronic medical records.,Adverse events after ICU admission Monitored and documented by clinical staff using predefined clinical criteria.,In-hospital mortality after ICU admission Monitored and documented by clinical staff using predefined clinical criteria.

Countries

Thailand

Contacts

Public ContactNatsuda Phothikun

Faculty of Medicine, Chiang Mai University, Chiang Mai

natsuda.dkptk@gmail.com0849090104

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 10, 2026